Chester County News and Community Website
NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) said its experimental lung cancer drug firmonertinib failed to significantly improve progression-free survival compared with chemotherapy in a pivotal Phase 3 …
ArriVent’s Lung Cancer Drug Fails Key Phase 3 Trial Endpoint Read More
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. secured a $3.17 million, five-year National Cancer Institute grant to advance an experimental radiopharmaceutical toward potential clinical testing in patients with non-small …
MTTI Lands $3.17 Million NCI Grant to Advance Lung Cancer Drug Read More
WASHINGTON, D.C. — U.S. cancer death rates declined for both men and women from 2019 through 2023, extending a more than two-decade drop driven largely by faster progress against lung …
Lung Cancer Gains Push U.S. Cancer Death Rates Lower Read More
WILMINGTON, DE — AstraZeneca (NYSE: AZN) and Daiichi Sankyo’s Enhertu extended median progression-free survival by six months versus pembrolizumab plus chemotherapy in a Phase III trial of first-line treatment for …
Enhertu Extends PFS by Six Months in HER2 Lung Cancer Read More WILMINGTON, DE — AstraZeneca’s (NYSE: AZN) Tagrisso showed a sustained survival benefit eight years after treatment in a Phase III trial of patients with early-stage EGFR-mutated non-small cell lung cancer, …
Tagrisso Cuts Death Risk 47% in Long-Term Lung Cancer Trial Read More WILMINGTON, DE — AstraZeneca’s Imfinzi combined with Amgen’s tarlatamab significantly extended overall survival in a Phase III trial of first-line extensive-stage small cell lung cancer, potentially expanding treatment options for …
AstraZeneca Lung Cancer Combo Extends Survival in Phase III Read More
HARRISBURG, PA — The American Lung Association Research Institute has opened its 2027-28 grant cycle to Pennsylvania researchers and other qualified scientists conducting U.S.-based studies, offering awards of up to …
Lung Association Opens 2027-28 Research Grant Cycle Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network said it selected four research projects for funding aimed at improving lung cancer screening rates and access to care in the …
NCCN Awards Funding for Lung Cancer Screening Research Projects Read More
WASHINGTON, D.C. — Federal health officials will begin offering free mobile health screenings for coal miners this month as part of a national program aimed at detecting black lung disease …
Free Black Lung Screenings Expand Across Coal Communities Read More
WASHINGTON, D.C. — The Food and Drug Administration has released draft guidance outlining a new pathway to approve highly individualized treatments for ultra-rare diseases and has granted expedited approval to …
FDA Unveils Ultra-Rare Therapy Path, Fast-Tracks Lung Drug Read More